EIC / EMA Info Day: Regulatory support for the development of innovative medicines and technologies

The European Innovation Council (EIC) and the European Medicines Agency (EMA) info day provides information about the wide range of support services provided by EMA to researchers, and SMEs active in research and innovation in the pharmaceutical and med-tech sectors.

The info day covers:

• how to engage with EMA at different development milestones;
• the range of EMA support services including those targeting gene and cell therapies, and orphan medicines;
• benefits of applying to the Innovation Task Force (ITF) services, PRIME and Scientific Advice, as well as practical details on how to prepare and submit applications;
• real examples of advice given through these services and testimonials from academic researchers and companies funded by the EIC Pathfinder and Accelerator programmes on their experience with EMA services.

• Agenda: EIC/EMA Info Day
• Speakers' biographies: EIC/EMA Info Day
• Presentation - An overview of EMA development support to innovative medicines and technologies (Leonor Enes, EMA)
• Innovation Task Force Services (ITF) (Falk Ehmann, EMA)
• Testimonial on Innovation Task Force Services (ITF) (Igor Balaz, EVONANO)
• Priority Medicines Scheme (PRIME) (Kevin Cunningham, EMA)
• EMA Scientific Advice (Iordanis Gravanis, EMA)
• Testimonial on Scientific Advice (Carles Domenech & Gemma Fierro, AbilityPharma)
• The parallel journeys from Academia to Enterprise & from ITF to Scientific Advice (Piotr Trzonkowski, PolTREG)